Welcome to our latest issue of EMJ Respiratory, featuring the most fascinating findings from this year’s European Respiratory Society (ERS) International Congress. This e-journal also includes articles on the aetiology of parenchyma of the lungs, the psychological effects of COVID-19, and pulmonary rehabilitation, as well as an interview with J. Brady Scott, Director of Clinical Education at Rush University, Chicago, Illinois, USA.
Latest articlesAll articles
Cutaneous Mucormycosis Co-infection in a Patient with COVID-19
A 54-year-old male tested positive in late February on a screening COVID-19 test performed after a family member’s test had become positive. A few weeks later, they presented to the emergency room at a different hospital centre with shortness of breath and fever.
Current Perspectives and Future Directions of Repeat Pulmonary Rehabilitation Programmes in People with Chronic Obstructive Pulmonary Disease: A Narrative Review of the Literature
The benefits of pulmonary rehabilitation (PR) diminish over 12–24 months following programme completion. A repeat PR programme may potentially prevent or reverse this decline in gains and may provide additional benefits.
Modulating the Expression of Multiple Surface Receptors on Epithelial Cells and Promoting Lung Macrophage Anti-viral Functions by OM-85 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection
The emergence of a new virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, in December 2019 triggered a global pandemic, forcing much of the world to adopt lockdown strategies and leading to extraordinary threats to the global healthcare system. The clinical manifestations of the disease, referred to as COVID-19, range from mild, self-limiting flu-like respiratory illness to life-threatening multi-organ failure and death.
An Observational Study on Unique High Resolution Computed Tomography Pattern of Post-COVID Pulmonary Fibrosis
The parenchyma of the lungs can undergo fibrosis due to known aetiology such as radiation or drug induced fibrosis; occupational or connective tissue related interstitial lung disease; or it may have genetic basis or remain idiopathic, as in idiopathic pulmonary fibrosis.